Suppr超能文献

2012 亚太血管炎和抗中性粒细胞胞浆抗体研讨会:大动脉炎的手术治疗。

The Asia Pacific meeting for vasculitis and ANCA workshop 2012: surgical treatment for Takayasu's arteritis.

机构信息

Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan,

出版信息

Clin Exp Nephrol. 2014 Apr;18(2):296-300. doi: 10.1007/s10157-013-0894-5. Epub 2013 Nov 22.

Abstract

Surgical interventions are performed to ameliorate the complications of Takayasu's arteritis, which adversely affects life expectancy. However, the efficacy of surgery in relation to long-term survival of the patients remains to be evaluated. A retrospective review was performed on 110 consecutive patients with Takayasu's arteritis who underwent surgical treatment at our single institution. Survival was compared with the reported results of medically treated patients according to Ishikawa's prognostic classification. There were 12 hospital deaths, and the remaining 98 patients were followed up from 10 months to 48.4 years (mean 21.6 years). A serious long-term complication was anastomotic aneurysms with a cumulative incidence at 10 and 20 years of 7.8 and 14.8 %, respectively. Thirty-seven late deaths were observed and the major causes were congestive heart failure and anastomotic aneurysms. The cumulative survival rate at 10 and 20 years was 84.3 and 70.4 %, respectively. In patients classified as stage 3 by Ishikawa, surgery seemed to increase survival; however, surgery-associated complications conversely decreased the survival of patients with stage 1 disease. Surgery seems to increase the long-term survival of patients with stage 3 Takayasu's arteritis by Ishikawa's prognostic classification. Conservative treatment is recommended for those with stage 1 or 2 disease. Anastomotic aneurysms may occur at any time after surgery, and regular follow-up is mandatory for the rest of the patient's life. This article was based on previous reports by the author with several additional patients and follow-up periods.

摘要

外科干预旨在改善 Takayasu 动脉炎的并发症,因为这些并发症会降低预期寿命。然而,手术对患者长期生存的疗效仍有待评估。我们对在我院接受单一手术治疗的 110 例 Takayasu 动脉炎连续患者进行了回顾性研究。将生存情况与 Ishikawa 预后分类报告的接受药物治疗患者的结果进行了比较。共有 12 例院内死亡,其余 98 例患者的随访时间为 10 个月至 48.4 年(平均 21.6 年)。严重的长期并发症是吻合口动脉瘤,10 年和 20 年的累积发生率分别为 7.8%和 14.8%。观察到 37 例晚期死亡,主要原因是充血性心力衰竭和吻合口动脉瘤。10 年和 20 年的累积生存率分别为 84.3%和 70.4%。在 Ishikawa 分期为 3 期的患者中,手术似乎提高了生存率;然而,手术相关并发症反而降低了 1 期疾病患者的生存率。根据 Ishikawa 的预后分类,手术似乎可以提高 3 期 Takayasu 动脉炎患者的长期生存率。建议对 1 期或 2 期疾病患者进行保守治疗。吻合口动脉瘤可能在手术后的任何时间发生,患者需要终身定期随访。本文基于作者以前的报告,增加了一些患者和随访时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验